Abbott India Limited (ABBOTINDIA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Abbott India Limited (ABBOTINDIA) has a cash flow conversion efficiency ratio of 0.130x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.22 Billion ≈ $56.45 Million USD) by net assets (Rs40.11 Billion ≈ $433.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Abbott India Limited (ABBOTINDIA) market capitalisation for the company's overall valuation and market capitalisation.
Abbott India Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Abbott India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Abbott India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Abbott India Limited ranked by their cash flow conversion efficiency. Explore Abbott India Limited (ABBOTINDIA) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guobo Electronics Co. Ltd. A
SHG:688375
|
N/A |
|
Nexgen Energy (Canada) Ltd
AU:NXG
|
-0.006x |
|
Morningstar Inc
NASDAQ:MORN
|
0.090x |
|
Yanzhou Coal Mining Company Limited
F:YZCA
|
0.000x |
|
NexGen Energy Ltd.
TO:NXE
|
-0.006x |
|
Wuxi Taiji Industry Co Ltd
SHG:600667
|
0.015x |
|
Healthcare Realty Trust Incorporated
NYSE:HR
|
0.033x |
|
Builders FirstSource Inc
NYSE:BLDR
|
0.017x |
Annual Cash Flow Conversion Efficiency for Abbott India Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Abbott India Limited from 2005 to 2025. View ABBOTINDIA share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs42.33 Billion ≈ $457.80 Million |
Rs10.12 Billion ≈ $109.43 Million |
0.239x | -27.10% |
| 2024-03-31 | Rs36.99 Billion ≈ $400.02 Million |
Rs12.13 Billion ≈ $131.16 Million |
0.328x | +17.02% |
| 2023-03-31 | Rs31.89 Billion ≈ $344.83 Million |
Rs8.93 Billion ≈ $96.62 Million |
0.280x | -16.63% |
| 2022-03-31 | Rs28.20 Billion ≈ $304.95 Million |
Rs9.48 Billion ≈ $102.49 Million |
0.336x | +20.33% |
| 2021-03-31 | Rs26.02 Billion ≈ $281.41 Million |
Rs7.27 Billion ≈ $78.59 Million |
0.279x | +8.47% |
| 2020-03-31 | Rs24.32 Billion ≈ $262.98 Million |
Rs6.26 Billion ≈ $67.71 Million |
0.257x | +3.61% |
| 2019-03-31 | Rs20.09 Billion ≈ $217.22 Million |
Rs4.99 Billion ≈ $53.98 Million |
0.248x | +175.47% |
| 2018-03-31 | Rs16.93 Billion ≈ $183.07 Million |
Rs1.53 Billion ≈ $16.51 Million |
0.090x | -59.27% |
| 2017-03-31 | Rs13.87 Billion ≈ $149.99 Million |
Rs3.07 Billion ≈ $33.22 Million |
0.222x | +6.50% |
| 2016-03-31 | Rs11.96 Billion ≈ $129.30 Million |
Rs2.49 Billion ≈ $26.89 Million |
0.208x | -9.21% |
| 2015-03-31 | Rs9.38 Billion ≈ $101.39 Million |
Rs2.15 Billion ≈ $23.23 Million |
0.229x | +53.60% |
| 2014-03-31 | Rs8.33 Billion ≈ $90.09 Million |
Rs1.24 Billion ≈ $13.44 Million |
0.149x | -4.81% |
| 2013-03-31 | Rs6.47 Billion ≈ $69.96 Million |
Rs1.01 Billion ≈ $10.96 Million |
0.157x | +254.26% |
| 2012-03-31 | Rs5.44 Billion ≈ $58.85 Million |
Rs240.66 Million ≈ $2.60 Million |
0.044x | -70.68% |
| 2011-03-31 | Rs3.05 Billion ≈ $33.03 Million |
Rs460.64 Million ≈ $4.98 Million |
0.151x | +10.24% |
| 2010-03-31 | Rs2.72 Billion ≈ $29.37 Million |
Rs371.57 Million ≈ $4.02 Million |
0.137x | -65.29% |
| 2009-03-31 | Rs2.21 Billion ≈ $23.93 Million |
Rs872.13 Million ≈ $9.43 Million |
0.394x | +196.26% |
| 2008-03-31 | Rs2.31 Billion ≈ $24.98 Million |
Rs307.40 Million ≈ $3.32 Million |
0.133x | -19.72% |
| 2007-03-31 | Rs2.46 Billion ≈ $26.58 Million |
Rs407.40 Million ≈ $4.41 Million |
0.166x | -2.57% |
| 2006-03-31 | Rs2.16 Billion ≈ $23.41 Million |
Rs368.20 Million ≈ $3.98 Million |
0.170x | -53.15% |
| 2005-03-31 | Rs1.88 Billion ≈ $20.36 Million |
Rs683.70 Million ≈ $7.39 Million |
0.363x | -- |
About Abbott India Limited
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, … Read more